rs147904376
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144991.3(TSPEAR):c.419C>A(p.Ala140Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000453 in 1,612,394 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_144991.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPEAR | NM_144991.3 | c.419C>A | p.Ala140Asp | missense_variant | 3/12 | ENST00000323084.9 | NP_659428.2 | |
TSPEAR | NM_001272037.2 | c.215C>A | p.Ala72Asp | missense_variant | 4/13 | NP_001258966.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPEAR | ENST00000323084.9 | c.419C>A | p.Ala140Asp | missense_variant | 3/12 | 1 | NM_144991.3 | ENSP00000321987.4 | ||
TSPEAR | ENST00000397916.1 | n.374C>A | non_coding_transcript_exon_variant | 3/11 | 1 | |||||
TSPEAR | ENST00000642437.1 | n.*364C>A | non_coding_transcript_exon_variant | 4/13 | ENSP00000496535.1 | |||||
TSPEAR | ENST00000642437.1 | n.*364C>A | 3_prime_UTR_variant | 4/13 | ENSP00000496535.1 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152146Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000648 AC: 16AN: 246846Hom.: 1 AF XY: 0.0000520 AC XY: 7AN XY: 134634
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460248Hom.: 2 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 726432
GnomAD4 genome AF: 0.000302 AC: 46AN: 152146Hom.: 0 Cov.: 29 AF XY: 0.000296 AC XY: 22AN XY: 74302
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 20, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 04, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 10, 2015 | The p.Ala140Asp variant in TSPEAR has not been previously reported in individual s with hearing loss, but has been identified in 8/9402 of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP r s147904376). Although this variant has been seen in the general population, its frequency is not high enough to rule out a pathogenic role. Computational predi ction tools and conservation analysis suggest that the p.Ala140Asp variant may n ot impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Ala140Asp vari ant is uncertain. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.419C>A (p.A140D) alteration is located in exon 3 (coding exon 3) of the TSPEAR gene. This alteration results from a C to A substitution at nucleotide position 419, causing the alanine (A) at amino acid position 140 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at